High Anti-Interferon-Alpha Autoantibody Levels in Severe/Critical COVID-19 Patients from Peru

Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis

(2023) Xi Wang et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Trends in the Intraindividual Double Burden of Overweight/Obesity and Anemia among Adult Women Living in 33 Low- and Middle-Income Countries: A Secondary Analysis of Demographic and Health Surveys from 2000-2019

(2023) Ana Irache et al.   JOURNAL OF NUTRITION

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

(2023) Daniela Matuozzo et al.   Genome Medicine

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital

(2022) Angélique Chauvineau-Grenier et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Human genetic and immunological determinants of critical COVID-19 pneumonia

(2022) Qian Zhang et al.   NATURE

Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity

(2022) Federica Frasca et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies

(2022) Bengisu Akbil et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

(2022) Alexis Mathian et al.   ANNALS OF THE RHEUMATIC DISEASES

COVID‐19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity

(2022) Wei Jiang et al.   JOURNAL OF MEDICAL VIROLOGY

The oldest unvaccinated Covid-19 survivors in South America

(2022) Mateus V. de Castro et al.   Immunity & Ageing

Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study

(2022) Romain Arrestier et al.   Annals of Intensive Care

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis

(2021) Santhamani Ramasamy et al.   CLINICAL MICROBIOLOGY REVIEWS

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study

(2021) Carlos Álvarez-Antonio et al.   Lancet Global Health

Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes

(2021) Emily Feng et al.   Cells

Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19

(2021) Michael S Abers et al.   IMMUNOLOGY AND CELL BIOLOGY

SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study

(2021) Charles Huamaní et al.   PeerJ

Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort

(2021) Maria J. Pons et al.   Frontiers in Immunology

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

(2021) Xavier Solanich et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Immunology of COVID-19: current state of the science

(2020) Nicolas Vabret et al.   IMMUNITY

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

(2020) Qian Zhang et al.   SCIENCE

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

(2020) Paul Bastard et al.   SCIENCE